ELF Q2 strong but margin pressures temper turnaround hopes

What happened

e.l.f. Beauty reported a strong fiscal Q2, with revenue up 51.4% and organic growth rebounding to 35%, while e.l.f. Cosmetics gained 30 basis points of market share. Management raised FY27 revenue growth guidance to 22–24%, reflecting continued momentum from the Rhode acquisition and core brand strength. However, the company cautioned that Rhode’s annualization, retail expansion costs, and reinvestment of tariff refunds will pressure growth rates and margins going forward. Despite the improving top line, the stock remains expensive relative to slowing underlying earnings growth, leaving the risk/reward unattractive. The market’s reaction has been mixed, with the stock still well below its prior highs as investors weigh the sustainability of this rebound against structural cost headwinds.

Implication

Investors should not chase the rally, as the raised guidance is already priced in and margin pressures from tariff refund reinvestment and Rhode integration are likely to keep earnings growth subdued. The key watch item is whether ex-Rhode organic growth can sustain above mid-single digits after the Q2 rebound; if it stalls again, the stock could de-rate further. A better risk/reward would emerge at a price closer to $65, where the downside scenario is more fully priced. Until then, trimming into strength above $105 may be prudent, as the stock remains around 64x trailing earnings with limited near-term catalysts to drive multiple expansion. The balance sheet remains manageable, but the high marketing spend required to maintain share gains leaves little cushion for operational missteps.

Thesis delta

The strong Q2 results and raised FY27 guidance partially offset our earlier concern about organic deceleration, forcing a modest upgrade from a potential sell to a hold. However, the structural risks of Rhode annualization and tariff refund reinvestment keeping margins suppressed mean the investment case is not compelling at current levels. We maintain a cautious stance, believing the stock still lacks a margin of safety and is vulnerable to multiple compression if growth disappoints.